Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure–activity relationship
Jin Xie(University of Kansas), H. T. Huang, Sumathy Mathialagan(Pfizer (United States)), Matthew T. Reding(Pfizer (United States)), Sheri L. Bonar(Washington University in St. Louis), Neetu Venkatraman(Pfizer (United States)), Shaun R. Selness(Pfizer (United States)), Cynthia D. Sommers(Pfizer (United States)), Sarah J. Brustkern(Pfizer (United States)), Natalie X. Chen(Pfizer (United States)), Richard F. Heier(Pfizer (United States)), Patrick J. Lennon(Pfizer (United States)), Nandini Kishore(Pfizer (United States)), Ravi G. Kurumbail(Northwestern University), Xiong Li(Central South University), Lori J. Christine(Pfizer (United States)), Serge G. Wolfson(Pfizer (United States)), Yiding Hu(Pfizer (United States)), Gennadiy Poda(Pfizer (United States))
Cited by 16
Related Papers
Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B
|Journal of Medicinal Chemistry|2002|467
Ferritin Nanocages To Encapsulate and Deliver Photosensitizers for Efficient Photodynamic Therapy against Cancer
|ACS Nano|2013|270
Chimeric Ferritin Nanocages for Multiple Function Loading and Multimodal Imaging
|Nano Letters|2011|263